What's in Abdi Ibrahim Ilac San. ve Tic A.S.'s pipeline?

Abdi Ibrahim Ilac San. ve Tic A.S. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Abdi Ibrahim Ilac San. ve Tic A.S.'s portfolio?

Top competitors by shared drug class: Ahn-Gook Pharmaceuticals Co.,Ltd, Beijing Tiantan Hospital, Bursa Yuksek Ihtisas Training and Research Hospital, Dongkook Pharmaceutical Co., Ltd., GlaxoSmithKline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abdi-ibrahim-ilac-san-ve-tic-a-s.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Abdi Ibrahim Ilac San. ve Tic A.S. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Abdi Ibrahim Ilac San. ve Tic A.S. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
AI201901	AI201901	phase 3	Unknown	Unknown	Unknown

Therapeutic area mix

Unknown · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
Bursa Yuksek Ihtisas Training and Research Hospital · 1 shared drug class
Dongkook Pharmaceutical Co., Ltd. · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Gloucestershire Hospitals NHS Foundation Trust · 1 shared drug class
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · 1 shared drug class
· 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Abdi Ibrahim Ilac San. ve Tic A.S.:

Cite this brief

Drug Landscape (2026). Abdi Ibrahim Ilac San. ve Tic A.S. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abdi-ibrahim-ilac-san-ve-tic-a-s. Accessed 2026-05-16.